VASRD 7904 · Musculoskeletal
Hyperparathyroidism is overproduction of parathyroid hormone, which pulls calcium out of bone and raises it in the blood, producing fatigue, nausea, constipation, kidney stones, reduced kidney function and progressive bone loss. Its classic skeletal form — osteitis fibrosa cystica, with bone pain, resorption and brown-tumour cysts — has no diagnostic code of its own and is rated as a residual of this condition under DC 7904.
| Rating | Criteria |
|---|---|
| 100% | A flat six months at 100 percent after parathyroid surgery |
| 60% | Hypercalcemia by lab value, or reduced kidney clearance, low bone density or a past fragility fracture |
| 10% | Symptoms persisting after surgery, or controlled only by continuous medication when surgery is not an option |
| 0% | Service-connected but currently causing no symptoms |
DC 7904 is structured around treatment rather than symptom severity. A 100 percent evaluation runs "for six months from date of discharge following surgery", and Note (1) then requires the rating to move to residuals: "After six months, rate on residuals under the appropriate diagnostic code(s) within the appropriate body system(s) based on a VA examination." The 60 percent evaluation is defined entirely by objective findings — total calcium above 12 mg/dL, ionized calcium above 5.6 mg/dL, creatinine clearance below 60 mL/min, a bone mineral density T-score below 2.5 SD, or a previous fragility fracture, any one of which suffices — and Notes (2) and (3) control how long it lasts: where surgery is indicated it continues until the day of surgery, and where surgery is not indicated it continues for six months after pharmacologic treatment begins. Ten percent covers "symptoms such as fatigue, anorexia, nausea, or constipation that occur despite surgery; or in individuals who are not candidates for surgery but require continuous medication for control", and an asymptomatic condition is zero percent. Note (4) is where the skeletal disease is actually evaluated: "Following surgery or other treatment, evaluate chronic residuals, such as nephrolithiasis (kidney stones), decreased renal function, fractures, vision problems, and cardiovascular complications, under the appropriate diagnostic codes." So osteitis fibrosa cystica, established bone loss and any pathological fracture are rated under the musculoskeletal codes for the parts affected — DC 5013 for osteoporosis residuals, the spine formula for a vertebral fracture — and combined with whatever DC 7904 itself provides. Osteitis deformans (Paget's disease, DC 5016) is a different disease with a different mechanism and should not be conflated with it.
Approval outlook
Low – typically secondary to hyperparathyroidism or renal failure.
Veterans service-connected
~140 veterans
Typical rating awarded
~10%
Vetrify editorial estimates informed by VA published claims data (VBA Annual Benefits Report) and the VA rating schedule — not official VA statistics.
Get the Hyperparathyroidism rating criteria, evidence checklist, and strategy tips delivered to your inbox so you can review them anytime.
Conditions commonly linked to Hyperparathyroidism. Service-connecting a secondary condition can increase your combined rating.
Fractures
Weakened bone structure leads to higher fracture risk
Hyperparathyroidism
Common underlying cause of bone breakdown
Rating criteria on this page are an educational summary of the cited regulation — the eCFR text is authoritative. See how Vetrify derives its numbers.
See how Hyperparathyroidism combines with your other service-connected conditions using the official VA combined-ratings formula.
Open the calculatorVA Calc: Disability Pay
Combine your ratings & see monthly pay on your iPhone · Works offline